Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

8.54
Delayed Data
As of Aug 26
 -0.06 / -0.70%
Today’s Change
5.57
Today|||52-Week Range
10.95
-20.85%
Year-to-Date
No recent news for Achillion Pharmaceuticals Inc.

Today’s Trading

Previous close8.60
Today’s open8.59
Day’s range8.41 - 8.73
Volume1,050,599
Average volume (3 months)1,334,222
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+94.29%
Earnings growth (this year)-1,479.06%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)--
P/E ratio77.6
Price/Sales20.49
Price/Book2.61

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...+1.16+3.10%
DEPODepomed Inc-0.07-0.35%
ACORAcorda Therapeutics ...-0.18-0.74%
PTLAPortola Pharmaceutic...+0.36+1.82%
Data as of 3:59pm ET, 08/26/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$66.1M
Annual profit (last year)-$5.0M
Net profit margin-7.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Executive VP &
Investor Relations Contact
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts

Partner Offers

NextAdvisor